JP3038370B2 - Method of creating suspension culture cell line - Google Patents

Method of creating suspension culture cell line

Info

Publication number
JP3038370B2
JP3038370B2 JP8245426A JP24542696A JP3038370B2 JP 3038370 B2 JP3038370 B2 JP 3038370B2 JP 8245426 A JP8245426 A JP 8245426A JP 24542696 A JP24542696 A JP 24542696A JP 3038370 B2 JP3038370 B2 JP 3038370B2
Authority
JP
Japan
Prior art keywords
cells
cell line
suspension culture
culture
niah
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP8245426A
Other languages
Japanese (ja)
Other versions
JPH1066563A (en
Inventor
昭彦 内村
茂樹 犬丸
康男 三浦
Original Assignee
農林水産省家畜衛生試験場長
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 農林水産省家畜衛生試験場長 filed Critical 農林水産省家畜衛生試験場長
Priority to JP8245426A priority Critical patent/JP3038370B2/en
Publication of JPH1066563A publication Critical patent/JPH1066563A/en
Application granted granted Critical
Publication of JP3038370B2 publication Critical patent/JP3038370B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、魚類由来浮遊培養
細胞株の作出方法、当該方法で作出した魚類由来浮遊培
養細胞株並びに当該細胞株を用いる伝染性魚病のワクチ
ン及び/又は診断用抗原の製造方法に関し、詳しくは魚
類由来付着性培養細胞株から浮遊培養細胞株を作出する
方法、当該方法で作出したコイ上皮腫由来浮遊培養細胞
株(EPC/NIAH細胞)及びニホンウナギ腎臓由来
浮遊培養細胞株(EK−1/NIAH細胞)並びに当該
細胞を用いて伝染性魚病のワクチン及び/又は診断用抗
原を製造する方法に関する。
The present invention relates to a method for producing a fish-derived suspension culture cell line, a fish-derived suspension culture cell line produced by the method, and a vaccine and / or diagnostic antigen for infectious fish disease using the cell line. More specifically, a method for producing a suspension culture cell line from a fish-derived adherent culture cell line, a carp epithelioma-derived suspension culture cell line (EPC / NIAH cells), and a Japanese eel kidney-derived suspension culture produced by the method The present invention relates to a cell line (EK-1 / NIAH cell) and a method for producing a vaccine for infectious fish disease and / or an antigen for diagnosis using the cell.

【0002】[0002]

【従来の技術】わが国の養殖漁業は、養殖技術の進歩に
伴い、養殖可能な魚種の増加、供給の安定性の向上など
目覚ましい発展を続けている。しかし、その反面、ウイ
ルス性疾病による養殖魚の大量斃死が近年急増してい
る。従来、これらの疾病への対処法としては、罹病魚の
排除、移動禁止等が行われているにすぎず、合理的な方
法の開発が望まれている。そのため、これらの疾病に対
して有効なワクチンや診断液の開発が望まれている。
2. Description of the Related Art The aquaculture fisheries in Japan have been making remarkable developments, such as an increase in fish species that can be cultured and an improvement in the stability of supply, with the progress of aquaculture technology. However, on the other hand, the mass mortality of farmed fish due to viral diseases has increased rapidly in recent years. Conventionally, as a method of coping with these diseases, only removal of diseased fish and prohibition of movement have been performed, and development of a rational method is desired. Therefore, development of vaccines and diagnostic solutions effective against these diseases is desired.

【0003】ワクチンや診断液の原料はウイルスである
が、当該ウイルスの大量培養に適した浮遊培養細胞株な
どの魚類由来細胞株は未だ殆ど開発されていない。その
上、魚類由来浮遊培養細胞株を開発する手法さえも確立
されていない。
[0003] The raw material of vaccines and diagnostic solutions is viruses, but fish-derived cell lines such as suspension culture cell lines suitable for mass culture of the virus have not been developed yet. Moreover, even a method for developing a fish-derived suspension culture cell line has not been established.

【0004】[0004]

【発明が解決しようとする課題】本発明の目的は、魚類
由来浮遊培養細胞株を作出する手法を確立し、当該手法
によるEPC/NIAH細胞、EK−1/NIAH細胞
等の魚類由来浮遊培養細胞株を作出することである。こ
れにより、魚類由来細胞の大量培養を容易に行うことが
でき、魚病ウイルスの大量生産が可能となる。その結
果、有効な魚病ワクチン等の生産と実用化に不可欠な技
術と材料を提供することができる。
SUMMARY OF THE INVENTION An object of the present invention is to establish a technique for producing a fish-derived suspension culture cell line, and to use the technique to produce a fish-derived suspension culture cell such as EPC / NIAH cells and EK-1 / NIAH cells. Creating a stock. This facilitates large-scale culture of fish-derived cells and enables large-scale production of fish disease virus. As a result, it is possible to provide techniques and materials essential for the production and practical application of effective fish disease vaccines and the like.

【0005】[0005]

【課題を解決するための手段】上記の課題を解決すべく
検討を重ねた結果、本発明者らは、目的とする魚類由来
浮遊培養細胞株を作出する方法を確立すると共に、コイ
上皮腫由来細胞株(EPC細胞)から浮遊培養細胞株
(EPC/NIAH細胞)を、ニホンウナギ腎臓由来細
胞株(EK−1細胞)から浮遊培養細胞株(EK−1/
NIAH細胞)を作出した。さらに、当該浮遊培養細胞
株を用いて伝染性魚病のワクチン及び/又は診断用抗原
を製造する方法を開発した。
As a result of repeated studies to solve the above-mentioned problems, the present inventors have established a method for producing a fish-derived suspension culture cell line of interest, and have also developed a carp epithelioma-derived cell line. The suspension culture cell line (EPC / NIAH cell) was converted from the cell line (EPC cell) to the suspension culture cell line (EK-1 /
NIAH cells). Furthermore, a method for producing an infectious fish disease vaccine and / or a diagnostic antigen using the suspension culture cell line has been developed.

【0006】請求項1に記載の発明は、魚類由来付着性
培養細胞株を浮遊培養用培地に馴化させながら継代培養
を行い、生じた浮遊性の細胞を、該細胞が浮遊培養用容
器の中心に集まり、2〜3cm幅を漂うように穏やかに
攪拌しながら培養することを特徴とする浮遊培養細胞株
の作出法である。請求項2に記載の発明は、請求項1記
載の作出法により、コイ上皮腫由来付着性培養細胞株か
ら作出した浮遊培養細胞株(EPC/NIAH細胞)
(FERMP−15793)である。請求項3に記載の
発明は、請求項1記載の作出法により、ニホンウナギ腎
臓由来付着性培養細胞株から作出した浮遊培養細胞株
(EK−1/NIAH細胞)(FERM P−1579
2)である。請求項4に記載の発明は、請求項2又は3
記載の浮遊培養細胞株を用いることを特徴とする伝染性
ウイルスによる魚病のワクチンの製造方法である。請求
項5に記載の発明は、請求項2又は3記載の浮遊培養細
胞株を用いることを特徴とする伝染性ウイルスによる魚
病の診断用抗原の製造方法である。
According to the first aspect of the present invention, the adherent cultured cell line derived from fish is subcultured while acclimating to a culture medium for suspension culture, and the resulting floating cells are removed from the culture medium for suspension culture.
Gather in the center of the bowl and gently float over a 2-3 cm width
This is a method for producing a suspension culture cell line characterized by culturing while stirring . The invention according to claim 2 provides a suspension culture cell line (EPC / NIAH cell) produced from a carp epithelioma-derived adherent culture cell line by the production method according to claim 1.
(FERMP-15793). The invention according to claim 3 provides a suspension culture cell line (EK-1 / NIAH cell) (FERM P-1579) produced from the adherent culture cell line derived from Japanese eel kidney by the production method according to claim 1.
2). The invention according to claim 4 is the invention according to claim 2 or 3
Infectivity characterized by using the suspension culture cell line described in the above.
This is a method for producing a vaccine for fish disease caused by a virus . A fifth aspect of the present invention is a method for producing an antigen for diagnosing fish disease caused by an infectious virus, comprising using the suspension culture cell line according to the second or third aspect.

【0007】[0007]

【発明の実施の形態】コイ上皮腫由来のEPC細胞やニ
ホンウナギ腎臓由来のEK−1細胞は、元来付着性細胞
であり、単層培養するとプラスチック培養瓶等の培養容
器に付着して増殖する。増殖した当該細胞に伝染性造血
器壊死症ウイルス、伝染性膵臓壊死症ウイルスなどを感
染させると、これらのウイルスをよく増殖させるという
特性を有している。そこで、本発明者らは、これらのウ
イルス増殖性を損ねないようにして、浮遊培養が可能な
細胞株の作出を試みた。すなわち、浮遊培養用培地に上
記の細胞を培養し、増殖した細胞を継代培養した。この
場合、容器壁などに付着した細胞を常法に従ってトリプ
シンとEDTAの混合溶液で処理して剥がした。また、
細胞が増殖して容器壁等に隙間なく完全な細胞層を形成
したり、細胞密度が過剰になった時点で、希釈して新し
い培地に移して培養を継続した。
BEST MODE FOR CARRYING OUT THE INVENTION EPC cells derived from carp epithelioma and EK-1 cells derived from Japanese eel kidney are originally adherent cells, and adhere to a culture vessel such as a plastic culture bottle and proliferate in monolayer culture. I do. When the proliferating cells are infected with infectious hematopoietic necrosis virus, infectious pancreatic necrosis virus, or the like, they have the property of proliferating these viruses well. Thus, the present inventors have attempted to create a cell strain that can be cultured in suspension without impairing the virus propagation properties. That is, the above cells were cultured in a suspension culture medium, and the grown cells were subcultured. In this case, the cells adhered to the container wall and the like were treated with a mixed solution of trypsin and EDTA according to a conventional method and peeled off. Also,
When the cells proliferated to form a complete cell layer without any gaps on the vessel wall or the like, or when the cell density became excessive, the cells were diluted and transferred to a new medium to continue the culture.

【0008】このようにして浮遊性の細胞を得た後、浮
遊培養用培地に馴化させながら培養した。このときの培
養は、静置培養が好ましい。浮遊性の細胞が生じた段階
でこれを回収した。その際、浮遊培養用培地への添加血
清および添加成分の種類および添加量等について検討し
た。すなわち、牛胎児血清,牛新生児血清,成牛血清,
8%濃度のポリエチレングリコールを添加して蛋白質を
除去した血清などを添加量を変えたり、さらにはトリプ
トースホスフェートブロス(3%),ラクトアルブミン
水解物(2%),バクトペプトン(1%)などと組み合
わせて添加したりして細胞増殖性や細胞維持性などに及
ぼす影響を調べた。その結果、EPC/NIAH細胞の
培養には成牛血清の添加が有効で、他の血清を添加した
場合よりも細胞増殖性が優れており、細胞凝集塊も形成
し難かった。また、EK−1/NIAH細胞の培養に
は、市販の牛胎児血清を添加したときに細胞増殖性が優
れていた。なお、血清の添加量は、浮遊性の細胞を得る
ときは1〜3%、通常は2%程度が適当であり、浮遊培
養時にはEPC/NIAH細胞の場合は5%程度、EK
−1/NIAH細胞の場合は10%程度が適当である。
しかし、トリプトースホスフェートブロス等を添加して
も、細胞の増殖性に良い影響を示さなかった。これらの
結果から、下記の方法で魚類由来の浮遊培養細胞株を作
出できることを見出した。
[0008] After obtaining the floating cells in this manner, the cells were cultured while being adapted to a medium for suspension culture. The culture at this time is preferably static culture. When free-floating cells formed, they were collected. At that time, the types and amounts of added serum and added components to the suspension culture medium were examined. Fetal bovine serum, newborn bovine serum, adult bovine serum,
The amount of serum or the like from which protein has been removed by adding 8% polyethylene glycol is changed, and the amount of trypsose phosphate broth (3%), lactalbumin hydrolyzate (2%), bactopeptone (1%), etc. The effect on cell proliferation, cell maintenance, etc., was examined by adding in combination with. As a result, the addition of adult bovine serum was effective for culturing EPC / NIAH cells, the cell proliferation was superior to the case where other serum was added, and cell aggregates were hardly formed. In addition, in the culture of EK-1 / NIAH cells, when commercially available fetal bovine serum was added, the cell proliferation was excellent. The amount of serum to be added is preferably 1 to 3% for obtaining floating cells, usually about 2%, and about 5% for EPC / NIAH cells during suspension culture.
In the case of -1 / NIAH cells, about 10% is appropriate.
However, addition of tryptose phosphate broth and the like did not show a favorable effect on cell proliferation. From these results, it was found that a suspension culture cell line derived from fish can be produced by the following method.

【0009】浮遊培養に用いる培養液としては、既知の
ものを使用することができ、例えば浮遊培養用イーグル
MEM培地(日水製薬(株)製)、Joklik's改変イーグ
ル培地(JRHバイオサイエンス社製)等は好適に用い
られる。上記のEPC細胞やEK−1細胞の培養にあた
っては、細胞付着性の少ない培養容器が好ましく、例え
ば浮遊培養細胞用プラスチック培養瓶が好適である。前
記細胞の培養は、通常静置培養により行う。増殖した細
胞を、前記のようにトリプシンとEDTAの混合溶液を
用いて容器壁などから剥がして培養液に分散させ、さら
には十分に増殖したときには、希釈して新しい培地に移
して培養を続ける、いわゆる継代培養することによっ
て、浮遊性の細胞を得る。
As the culture solution used for the suspension culture, known ones can be used. For example, Eagle MEM medium for suspension culture (manufactured by Nissui Pharmaceutical Co., Ltd.), Joklik's modified Eagle medium (manufactured by JRH Bioscience) Etc. are preferably used. In culturing the above-mentioned EPC cells and EK-1 cells, a culture vessel with low cell adhesion is preferable, and for example, a plastic culture bottle for suspension culture cells is suitable. The culturing of the cells is usually performed by stationary culture. The grown cells are peeled off from the container wall or the like using the mixed solution of trypsin and EDTA as described above and dispersed in the culture solution, and further when sufficiently grown, diluted and transferred to a new medium to continue the culture. By so-called subculture, floating cells are obtained.

【0010】次いで、この細胞を浮遊培養用培地(例え
ば、浮遊培養用イーグルMEM培地やJoklik's改変イー
グル培地)に馴化させる。このとき、EPC/NIAH
細胞の培養には、2%程度の成牛血清の添加が有効であ
り、EK−1/NIAH細胞の培養には、2%程度の牛
胎児血清を添加が有効である。各細胞はこれらの培地に
馴化させる。馴化した細胞は、トリプシン、EDTAを
用いた継代を行わずに培養液の交換を繰り返しながら維
持する。なお、培養液の交換は、EPC/NIAH細胞
の培養の場合は3〜4週間程度、EK−1/NIAH細
胞の培養の場合は10日間前後が適当である。培養温度
は28℃程度が適当である。培養上清中に浮遊細胞が生
じ始めて(顕微鏡観察による)も細胞維持を続け、浮遊
細胞数が増えた時点で培養容器を、内容物の偏りが生じ
ないように穏やかに攪拌できる振盪機(例えば、ザ・ベ
リーダンサー・シェーカー(STOVALL ライフサイエンス
社製))上に移し、静かに浮遊培養を行う。すなわち、
細胞が浮遊培養用容器の中心に集まり、その細胞が2〜
3cm幅を漂うくらいの振盪の強さで培養する。培養の
温度は25〜30℃、通常は28℃程度が適当であり、
培養時間は約7〜10日間である。
Next, the cells are adapted to a culture medium for suspension culture (for example, Eagle MEM medium for suspension culture or Joklik's modified Eagle medium). At this time, EPC / NIAH
About 2% of adult bovine serum is effective for culturing cells, and about 2% of fetal bovine serum is effective for culturing EK-1 / NIAH cells. Each cell is adapted to these media. The acclimated cells are maintained by repeatedly exchanging the culture solution without subculture using trypsin and EDTA. The culture medium is appropriately exchanged for about 3 to 4 weeks in the case of culturing EPC / NIAH cells, and about 10 days in the case of EK-1 / NIAH cells. A suitable culture temperature is about 28 ° C. The cells continue to be maintained even after suspension cells start to be generated in the culture supernatant (according to microscopic observation), and when the number of suspension cells increases, the culture vessel is shaken gently so that the contents are not biased (for example, a shaker (eg, , The belly dancer shaker (manufactured by STOVALL Life Science) and gently perform suspension culture. That is,
The cells collect in the center of the suspension culture vessel,
Incubate with a shaking intensity that floats 3 cm wide. The temperature of the culture is suitably 25 to 30 ° C, usually about 28 ° C,
The culturing time is about 7 to 10 days.

【0011】このようにして作出した浮遊培養細胞株、
EPC/NIAH細胞およびEK−1/NIAH細胞
は、工業技術院生命工学工業技術研究所に寄託されてい
る。その受託番号は、前者がFERM P−1579
3、後者がFERM P−15792である。
[0011] The suspension culture cell line thus produced,
EPC / NIAH cells and EK-1 / NIAH cells have been deposited with the National Institute of Bioscience and Biotechnology at the National Institute of Advanced Industrial Science and Technology. The deposit number is FERM P-1579
3. The latter is FERM P-15792.

【0012】このようにして作出した浮遊培養細胞株で
あるEPC/NIAH細胞やEK−1/NIAH細胞を
用いて伝染性造血器壊死症ウイルス、伝染性膵臓壊死症
ウイルス、ブリのウイルス性腹水症ウイルス等のワクチ
ン及び/又は診断用抗原を製造するには、公知の方法を
適用すればよい。例えば、ローラーボトルを用いた細胞
培養法やタンク培養法等を用いて、上記浮遊性細胞株に
感染させたウイルスを増殖させ、ウイルス原液を製造す
る方法を適用することができる。
Infectious hematopoietic necrosis virus, infectious pancreatic necrosis virus, and viral ascites of yellowtail using the EPC / NIAH cells and EK-1 / NIAH cells which are suspension culture cell lines thus produced. A known method may be applied to produce a vaccine such as a virus and / or a diagnostic antigen. For example, a method of producing a virus stock solution by growing a virus infected with the above-mentioned buoyant cell line using a cell culture method or a tank culture method using a roller bottle can be applied.

【0013】[0013]

【実施例】次に、実施例を挙げて本発明を詳細に説明す
る。 実施例1 親細胞であるEPC細胞を、成牛血清を5%含む浮遊培
養用イーグルMEM培地を用いて28℃で3〜4週間培
養した。培養終了後、培養上清を除去した後、増殖した
細胞をトリプシンとEDTAで処理した。すなわち、
0.1%トリプシンと0.02%EDTAの混合液を加
え、28℃のフラン器にて数分間保温し、顕微鏡で細胞
が丸くなって剥がれ始めたことを確認してから、新しい
培養液を加え、細胞密度が4〜5倍希釈になるように調
製した後、新しい培養用容器に分注した。この継代を2
2代行ったところ、培養上清中に浮遊性の細胞が生じ
た。この浮遊性の細胞を浮遊培養細胞用プラスチック培
養瓶に入れ、内容物の偏りが生じないように穏やかに攪
拌できる振盪機(ザ・ベリーダンサー・シェーカー:ST
OVALL ライフサイエンス社製)上で28℃にて7〜10
日間隔で培養した。
Next, the present invention will be described in detail with reference to examples. Example 1 EPC cells as parent cells were cultured at 28 ° C. for 3 to 4 weeks using an Eagle MEM medium for suspension culture containing 5% of adult bovine serum. After completion of the culture, the culture supernatant was removed, and the grown cells were treated with trypsin and EDTA. That is,
A mixed solution of 0.1% trypsin and 0.02% EDTA was added, and the mixture was kept warm for 28 minutes in a 28 ° C. flannel. After confirming that the cells had become rounded and began to peel off, a new culture solution was added. In addition, the cells were adjusted so that the cell density became 4 to 5 times, and then dispensed into a new culture vessel. This passage 2
After two passages, floating cells were generated in the culture supernatant. The suspension cells are placed in a plastic culture bottle for suspension culture cells, and the shaker (The Belly Dancer Shaker: ST) can be gently agitated so that the contents are not biased.
OVALL Life Science Co., Ltd.) at 28 ° C 7-10
Cultures were made at daily intervals.

【0014】このようにして培養した細胞は、スピンナ
ーフラスコによる浮遊培養や高速回転培養(8rpm)
による浮遊培養でも増殖可能で、57代以上継代しても
この性状は変わらなかった。この細胞を、魚類由来の浮
遊細胞株としてEPC/NIAH細胞と命名した。この
細胞は、前述したように、工業技術院生命工学工業技術
研究所に寄託されており、その受託番号は、FERM
P−15793である。
The cells cultured in this manner are subjected to suspension culture using a spinner flask or high-speed rotation culture (8 rpm).
Proliferation was also possible in suspension culture with E. coli, and this property did not change even after passage for 57 generations or more. These cells were designated as EPC / NIAH cells as a fish-derived floating cell line. As described above, this cell has been deposited with the National Institute of Advanced Industrial Science and Technology, and the accession number is FERM.
P-15793.

【0015】実施例2 実施例1で得たEPC/NIAH細胞の増殖性を調べ
た。すなわち、成牛血清を5%添加した浮遊培養用イー
グルMEM培地に当該細胞を接種し、28℃で18日
間、8rpmで高速回転浮遊培養を行った。このときの
増殖曲線を図1に示す。当該細胞の増殖を培養液中の遠
心沈降細胞重量部で表記すると、図から明らかなよう
に、1.0g/Lでまきこんだ細胞が6〜8日間で3.
5〜4g/Lに増殖した。
Example 2 The proliferation of the EPC / NIAH cells obtained in Example 1 was examined. That is, the cells were inoculated into Eagle's MEM medium for suspension culture to which 5% of adult bovine serum was added, and high-speed rotation suspension culture was performed at 28 rpm at 8 rpm for 18 days. The growth curve at this time is shown in FIG. When the proliferation of the cells is expressed in terms of parts by weight of the centrifuged sedimented cells in the culture solution, as is apparent from the figure, the cells spread at 1.0 g / L in 3 to 8 days.
It grew to 5-4 g / L.

【0016】実施例3 実施例2においてEPC/NIAH細胞の培養温度を1
3℃に変えたこと以外は実施例2と同様に行った。この
ときの結果を図2に示す。図から明らかなように、2r
pmの回転培養による浮遊培養を1ヵ月間続けても、細
胞の生存率は80%以上と非常に高いものであった。
Example 3 In Example 2, the culture temperature of EPC / NIAH cells was set to 1
The procedure was performed in the same manner as in Example 2 except that the temperature was changed to 3 ° C. The result at this time is shown in FIG. As is clear from the figure, 2r
Even if suspension culture by pm rotation culture was continued for one month, the cell survival rate was as high as 80% or more.

【0017】実施例4 実施例1で得たEPC/NIAH細胞の伝染性造血器壊
死症ウイルスに対する感受性を調べた。すなわち、EP
C/NIAH細胞に当該ウイルスを感染の多重度(m.o.
i.)=0.1で接種し、2%牛胎児血清加浮遊培養用イ
ーグルMEM培地を加えて振盪培養し、培養上清中のウ
イルス感染価を測定したところ、約2日後に109TCI
50/mlのレベルに増殖し、10日間経過後もこのレ
ベルを保持した。これは、親株であるEPC細胞と同レ
ベルであった。この結果を図3に示す。図中の○はEP
C細胞でのウイルスIHNV N−4株のウイルス感染
価を、●はEPC/NIAH細胞でのウイルスIHNV
N−4株のウイルス感染価を示し、□はEPC細胞で
のウイルスIHNV Y−2株のウイルス感染価を、■
はEPC/NIAH細胞でのウイルスIHNV Y−2
株のウイルス感染価を示し、△はEPC細胞でのウイル
スIHNV Y−6株のウイルス感染価を、▲はEPC
/NIAH細胞でのウイルスIHNV Y−6株のウイ
ルス感染価を示す。図から明らかなように、EPC/N
IAH細胞でのIHNVの増殖は、N−4株とY−2株
のウイルスでは接種後2〜4日で109.5 TCID50
ml、Y−6株では106.25TCID50/mlであり、
親株細胞でのウイルス増殖性とほぼ同じであった。この
ことから、当該細胞はワクチンおよび診断用抗原製造用
の細胞として有用であることが解明された。さらに、当
該細胞に感受性のあるウイルスによる疾病のワクチンの
製造用細胞としても有用であると考えられる。
Example 4 The susceptibility of the EPC / NIAH cells obtained in Example 1 to infectious hematopoietic necrosis virus was examined. That is, EP
C / NIAH cells were infected with the virus at a multiplicity (mo
i.) = inoculated with 0.1, 2% fetal bovine serum pressurized suspension culture for the Eagle's MEM medium with shaking culture in addition, measurement of the virus infection titer in the culture supernatant, about two days after the 10 9 TCI
Proliferated to a level of D 50 / ml and maintained this level after 10 days. This was at the same level as the parent EPC cells. The result is shown in FIG. ○ in the figure is EP
The virus infectivity titer of the virus IHNV N-4 strain in C cells and the black circles are the virus IHNV in EPC / NIAH cells.
The virus infectivity of the N-4 strain is shown, and □ is the virus infectivity of the virus IHNV Y-2 in EPC cells.
Is the virus IHNV Y-2 in EPC / NIAH cells
Indicates the virus infectivity of the strain, Δ indicates the virus infectivity of the virus IHNV Y-6 in EPC cells, and は indicates the EPC.
14 shows the viral infectivity of the virus IHNV Y-6 strain in S./NIAH cells. As is clear from the figure, EPC / N
The growth of IHNV in IAH cells was 10 9.5 TCID 50 / 2-4 days after inoculation for viruses of strains N-4 and Y-2.
ml, a 10 6.25 TCID 50 / ml in Y-6 strain,
It was almost the same as the virus multiplication in the parent cell line. This revealed that the cells were useful as cells for producing vaccines and diagnostic antigens. Furthermore, it is considered that the cell is also useful as a cell for producing a vaccine for a disease caused by a virus susceptible to the cell.

【0018】実施例5 親細胞であるEK−1細胞を、牛胎児血清5%、L−1
5培地を20%含む浮遊培養用イーグルMEM培地を用
いて28℃で7〜10日間培養し、増殖した細胞を前記
実施例1と同様にトリプシンとEDTAで処理して4〜
5倍希釈した後、この細胞を8代継代したところ、培養
上清中に浮遊性の細胞が生じた。この浮遊性の細胞を浮
遊培養細胞用プラスチック培養瓶に入れ、内容物の偏り
が生じないように穏やかに攪拌できる振盪機(ザ・ベリ
ーダンサー・シェーカー:STOVALL ライフサイエンス社
製)上で28℃にて7〜10日間培養した。
Example 5 The parental cell, EK-1 cell, was prepared by adding 5% fetal bovine serum and L-1
5 medium was cultured at 28 ° C. for 7 to 10 days using an Eagle MEM medium for suspension culture containing 20% of the 5 medium, and the grown cells were treated with trypsin and EDTA in the same manner as in Example 1 to obtain 4 to 4 days.
After a 5-fold dilution, the cells were passaged for 8 passages, resulting in floating cells in the culture supernatant. Put these buoyant cells into a plastic culture bottle for suspension culture cells, and raise the temperature to 28 ° C on a shaker (The Belly Dancer Shaker: STOVALL Life Science) that can gently agitate so that the contents do not become uneven. For 7 to 10 days.

【0019】このようにして培養した細胞は、スピンナ
ーフラスコによる浮遊培養や高速回転培養(8rpm)
による浮遊培養でも増殖可能で、27代以上継代して
も、この性状は変わらなかった。この細胞を、魚類由来
の浮遊培養細胞株としてEK−1/NIAH細胞と命名
した。この細胞は、前述したように、工業技術院生命工
学工業技術研究所に寄託されており、その受託番号は、
FERM P−15792である。
The cells cultured in this manner are subjected to suspension culture using a spinner flask or high-speed rotation culture (8 rpm).
Proliferation was also possible by suspension culture with E. coli, and this property did not change even if the cells were passaged for 27 or more passages. These cells were designated as EK-1 / NIAH cells as a fish-derived suspension culture cell line. As described above, this cell has been deposited with the National Institute of Advanced Industrial Science and Technology,
FERM P-15792.

【0020】実施例6 実施例5で得たEK−1/NIAH細胞の増殖性を調べ
た。すなわち、牛胎児血清10%、L−15培地を20
%含む浮遊培養用イーグルMEM培地に当該細胞を接種
し、28℃で6日間、8rpmで高速回転浮遊培養を実
施した。このときの増殖曲線を図4に示す。当該細胞の
増殖を培養液中の遠心沈降細胞重量部で表記すると、図
から明らかなように、1.0g/Lでまきこんだ細胞が
4〜6日間で3.5〜4g/Lに増殖した。
Example 6 The proliferation of the EK-1 / NIAH cells obtained in Example 5 was examined. That is, 10% fetal bovine serum and 20% L-15 medium were used.
% Of the cells were inoculated into Eagle's MEM medium for suspension culture, and high-speed rotation suspension culture was performed at 28 rpm at 8 rpm for 6 days. The growth curve at this time is shown in FIG. When the proliferation of the cells is expressed in terms of parts by weight of the centrifuged sedimented cells in the culture solution, as apparent from the figure, the cells spread at 1.0 g / L grew to 3.5 to 4 g / L in 4 to 6 days. .

【0021】実施例7 実施例6においてEK−1/NIAH細胞の培養温度を
13℃に変えたこと以外は実施例6と同様に行った。こ
のときの結果を図5に示す。図から明らかなように、2
rpmの回転培養による浮遊培養を1ヵ月以上続けて
も、生存率は80%以上を示した。
Example 7 The procedure of Example 6 was repeated, except that the culture temperature of EK-1 / NIAH cells was changed to 13 ° C. The result at this time is shown in FIG. As is clear from the figure, 2
Even if suspension culture by rotation culture at rpm was continued for 1 month or more, the survival rate was 80% or more.

【0022】実施例8 実施例5で得たEK−1/NIAH細胞の伝染性膵臓壊
死症ウイルスに対する感受性を調べた。すなわち、EK
−1/NIAH細胞に当該ウイルスをm.o.i.=0.1で
接種し、牛胎児血清2%、L−15培地を20%含む浮
遊培養用イーグルMEM培地を加えて振盪培養し、培養
上清中のウイルス感染価を測定したところ、約4日で1
09〜1010 TCID50/mlのレベルに増殖し、10日
目以降まで、同レベルを保った。これは、親株であるE
K−1細胞と同レベルであった。この結果を図6に示
す。図中の○はEK−1細胞でのウイルスIPNV A
b株のウイルス感染価を、●はEK−1/NIAH細胞
でのウイルスIPNV Ab株のウイルス感染価を示
し、□はEK−1細胞でのウイルスIPNV SP株の
ウイルス感染価を、■はEK−1/NIAH細胞でのウ
イルスIPNV SP株のウイルス感染価を示し、△は
EK−1細胞でのウイルスIPNV VR299株のウ
イルス感染価を、▲はEK−1/NIAH細胞でのウイ
ルスIPNV VR299株のウイルス感染価を示す。
図から明らかなように、EK−1/NIAH細胞でのI
PNVの増殖は、Ab株とSP株のウイルスでは接種後
4〜6日で109.0 〜1010.0TCID50/ml、VR
299株のウイルスでは接種後10日で109.0 TCI
50/mlであり、親株でのウイルス増殖性とほぼ同程
度であった。
Example 8 The sensitivity of the EK-1 / NIAH cells obtained in Example 5 to infectious pancreatic necrosis virus was examined. That is, EK
-1 / NIAH cells were inoculated with the virus at moi = 0.1, Eagle's MEM medium for suspension culture containing 2% of fetal calf serum and 20% of L-15 medium was added, and the cells were shake-cultured. When the virus infection titer was measured, it was 1 in about 4 days.
0 9 10 10 grow to the level of the TCID 50 / ml, up to 10 days later, keeping the same level. This is the parent stock E
It was at the same level as K-1 cells. The result is shown in FIG. The circle in the figure indicates the virus IPNVA in EK-1 cells.
b, the virus infectivity of the virus IPNV Ab strain in EK-1 / NIAH cells, □, the virus infectivity of the virus IPNV SP strain in EK-1 cells, and ■, EK -1 / NIAH cells show the virus infectivity of the virus IPNV SP strain, △ shows the virus infectivity of the virus IPNV VR299 strain in EK-1 cells, and ▲ shows the virus IPNV VR299 strain in EK-1 / NIAH cells. FIG.
As is clear from the figure, I in EK-1 / NIAH cells
The growth of PNV was between 10 9.0 and 10 10.0 TCID 50 / ml at 4 to 6 days after inoculation for the Ab strain and SP strain virus, VR
For 299 strains of virus, 10 9.0 TCI 10 days after inoculation
D 50 / ml, which was almost the same as that of the parent strain.

【0023】実施例9 EK−1/NIAH細胞のブリのウイルス性腹水症ウイ
ルスYAV株に対する感受性を調べた。すなわち、ウイ
ルスYAV株をm.o.i.=0.1で接種し、牛胎児血清2
%、L−15培地を20%含む浮遊培養用イーグルME
M培地を加えて振盪培養し、培養上清中のウイルス感染
価を測定したところ、約4日で108〜109TCID50
mlのレベルに増殖し、10日目以降まで、同レベルを
保った。これは、親細胞であるEK−1細胞と同レベル
の感受性である。この結果を図7に示す。なお、図中の
○はEK−1細胞でのウイルスYAV株の感染価を、●
はEK−1/NIAH細胞でのウイルスYAV株の感染
価をを示す。図から明らかなように、EK−1/NIA
H細胞でのウイルスYAV株の増殖は、接種後8日で1
9.0 TCID50/mlであり、親株でのウイルス増殖
性とほぼ同程度であった。実施例5〜9の結果から、E
K−1/NIAH細胞がワクチンおよび診断用抗原製造
用の細胞として有用であることが解明された。さらに、
当該細胞に感受性のあるウイルスによる疾病のワクチン
の製造用細胞としても有用であると考えられる。
Example 9 The sensitivity of EK-1 / NIAH cells to viral ascites virus YAV strain of yellowtail was examined. That is, the virus YAV strain was inoculated at moi = 0.1 and bovine fetal serum 2
%, Eagle ME for suspension culture containing 20% L-15 medium
Shake culture by adding M medium was measured viral infection titer in the culture supernatant, approximately 4 days at 10 8 ~10 9 TCID 50 /
Proliferated to the ml level and remained the same until day 10 onwards. It is as sensitive as the parental EK-1 cell. The result is shown in FIG. In the figure, ○ indicates the infectivity of the virus YAV strain in EK-1 cells,
Indicates the infectivity of the virus YAV strain in EK-1 / NIAH cells. As is clear from the figure, EK-1 / NIA
Propagation of the virus YAV strain in H cells was 1 day 8 days after inoculation.
09.0 TCID 50 / ml, which was almost the same as that of the parent strain. From the results of Examples 5 to 9, E
It has been elucidated that K-1 / NIAH cells are useful as cells for producing vaccines and diagnostic antigens. further,
It is also considered useful as a cell for producing a vaccine for a disease caused by a virus susceptible to the cell.

【0024】[0024]

【発明の効果】本発明により、以下に指摘する効果が奏
される。 魚類由来の浮遊細胞株浮遊培養細胞株が作出できるの
で、容易に魚類由来細胞と魚病の病原ウイルスの大量培
養が可能になる。 EPC/NIAH細胞では、伝染性造血器壊死症ウイ
ルスがよく増殖するので、この細胞を伝染性造血器壊死
症のワクチン等の生物学的製剤の製造に使用することに
より、ワクチンの実用化を図ることができる。 EK−1/NIAH細胞では、伝染性膵臓壊死症ウイ
ルスやブリのウイルス性腹水症ウイルスがよく増殖する
ので、この細胞を伝染性膵臓壊死症やブリのウイルス性
腹水症のワクチン等の生物学的製剤の製造に使用するこ
とにより、ワクチンの実用化を図ることができる。 EPC/NIAH細胞やEK−1/NIAH細胞は、
他のウイルス性の魚病に対するワクチン等の生物学的製
剤の製造に応用可能である。
According to the present invention, the following effects can be obtained. Since a fish-derived suspension cell line can be produced, a large-scale culture of fish-derived cells and fish disease-causing virus can be easily performed. Infectious hematopoietic necrosis virus proliferates well in EPC / NIAH cells, and the cells are used for the production of biological products such as vaccines for infectious hematopoietic necrosis, thereby realizing the vaccine. be able to. In EK-1 / NIAH cells, infectious pancreatic necrosis virus and yellowtail viral ascites virus proliferate well, and these cells can be used for biological treatment of infectious pancreatic necrosis and yellowtail viral ascites vaccine. The vaccine can be put to practical use by using it for production of a preparation. EPC / NIAH cells and EK-1 / NIAH cells
It is applicable to the production of biological products such as vaccines against other viral fish diseases.

【図面の簡単な説明】[Brief description of the drawings]

【図1】 高速回転培養法による浮遊培養でのEPC/
NIAH細胞の増殖曲線である。
Fig. 1. EPC / suspension culture by high-speed rotation culture
It is a proliferation curve of a NIAH cell.

【図2】 13℃でのEPC/NIAH細胞の保存性を
示す。
FIG. 2 shows the storage stability of EPC / NIAH cells at 13 ° C.

【図3】 EPC/NIAH細胞での伝染性造血器壊死
症ウイルスの増殖曲線である。
FIG. 3 is a growth curve of infectious hematopoietic necrosis virus on EPC / NIAH cells.

【図4】 高速回転培養砲による浮遊培養でのEK−1
/NIAH細胞の増殖曲線である。
FIG. 4. EK-1 in suspension culture using a high-speed rotating culture gun
9 is a proliferation curve of the / NIAH cells.

【図5】 13℃でのEK−1/NIAH細胞の保存性
を示す。
FIG. 5 shows the storage stability of EK-1 / NIAH cells at 13 ° C.

【図6】 EK−1/NIAH細胞での伝染性膵臓壊死
症ウイルスの増殖曲線である。
FIG. 6 is a growth curve of infectious pancreatic necrosis virus in EK-1 / NIAH cells.

【図7】 EK−1/NIAH細胞でのブリのウイルス
性腹水症ウイルスの増殖曲線である。
FIG. 7 is a growth curve of yellowtail viral ascites virus on EK-1 / NIAH cells.

───────────────────────────────────────────────────── フロントページの続き (56)参考文献 魚病研究,1990,Vol.25,No. 2,p.69−79 魚病研究,1995,Vol.30,No. 1,p.47−52 魚病研究,1996,Vol.31,No. 2,p.59−63 「特別研究・別枠研究成果の概要」, 農林水産技術会議事務局,平成6年11 月,p.78−80 (58)調査した分野(Int.Cl.7,DB名) C12N 5/00 JICSTファイル(JOIS)────────────────────────────────────────────────── ─── Continued on the front page (56) References Fish Disease Research, 1990, Vol. 25, No. 2, p. 69-79 Fish Disease Research, 1995, Vol. 30, No. 1, p. 47-52 Fish Disease Research, 1996, Vol. 31, No. 2, p. 59-63 “Summary of Special Research / Research Results”, Secretariat of the Agriculture, Forestry and Fisheries Technology Council, November 1994, p. 78-80 (58) Field surveyed (Int. Cl. 7 , DB name) C12N 5/00 JICST file (JOIS)

Claims (5)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 魚類由来付着性培養細胞株を浮遊培養用
培地に馴化させながら継代培養を行い、生じた浮遊性の
細胞を、該細胞が浮遊培養用容器の中心に集まり、2〜
3cm幅を漂うように穏やかに攪拌しながら培養するこ
とを特徴とする魚類細胞の浮遊培養細胞株の作出方法。
1. A subculture is carried out while acclimating a fish-derived adherent culture cell line to a suspension culture medium, and the resulting suspension cells are collected at the center of a suspension culture container,
A method for producing a suspension-cultured cell line of fish cells, which comprises culturing while gently stirring to float a 3 cm width .
【請求項2】 請求項1記載の作出方法により、コイ上
皮腫由来付着性培養細胞株から作出した浮遊培養細胞株
(EPC/NIAH細胞)(FERM P−1579
3)。
2. A suspension culture cell line (EPC / NIAH cell) (FERM P-1579) produced from a carp epithelioma-derived adherent culture cell line by the production method according to claim 1.
3).
【請求項3】 請求項1記載の作出方法により、ニホン
ウナギ腎臓由来付着性培養細胞株から作出した浮遊培養
細胞株(EK−1/NIAH細胞)(FERMP−15
792)。
3. A suspension culture cell line (EK-1 / NIAH cell) (FERMP-15) produced from the adherent culture cell line derived from Japanese eel kidney by the production method according to claim 1.
792).
【請求項4】 請求項2又は3記載の浮遊培養細胞株を
用いることを特徴とする伝染性ウイルスによる魚病のワ
クチンの製造方法
4. A fish disease caused by an infectious virus, wherein the suspension culture cell line according to claim 2 or 3 is used.
A method for producing Kuching .
【請求項5】 請求項2又は3記載の浮遊培養細胞株を
用いることを特徴とする伝染性ウイルスによる魚病の診
断用抗原の製造方法
5. The suspension culture cell line according to claim 2 or 3.
Diagnosis of fish disease caused by infectious virus, characterized by using
A method for producing a sever antigen .
JP8245426A 1996-08-29 1996-08-29 Method of creating suspension culture cell line Expired - Lifetime JP3038370B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8245426A JP3038370B2 (en) 1996-08-29 1996-08-29 Method of creating suspension culture cell line

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8245426A JP3038370B2 (en) 1996-08-29 1996-08-29 Method of creating suspension culture cell line

Publications (2)

Publication Number Publication Date
JPH1066563A JPH1066563A (en) 1998-03-10
JP3038370B2 true JP3038370B2 (en) 2000-05-08

Family

ID=17133487

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8245426A Expired - Lifetime JP3038370B2 (en) 1996-08-29 1996-08-29 Method of creating suspension culture cell line

Country Status (1)

Country Link
JP (1) JP3038370B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5134964B2 (en) * 2005-10-05 2013-01-30 ジェノミディア株式会社 Isolated human cells, methods for obtaining the same and uses thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
「特別研究・別枠研究成果の概要」,農林水産技術会議事務局,平成6年11月,p.78−80
魚病研究,1990,Vol.25,No.2,p.69−79
魚病研究,1995,Vol.30,No.1,p.47−52
魚病研究,1996,Vol.31,No.2,p.59−63

Also Published As

Publication number Publication date
JPH1066563A (en) 1998-03-10

Similar Documents

Publication Publication Date Title
US4016036A (en) Process for serially culturing keratinocytes
Wolfe et al. Induction of tumors in marmoset monkeys by simian sarcoma virus, type 1 (Lagothrix): a preliminary report
CN1228119B (en) Immortalized cell lines for virus growth
US6117674A (en) Pathogen propagation in cultured three-dimensional tissue mass
Okada et al. The retention of differentiated properties by lens epithelial cells in clonal cell culture
Fryer et al. A cell line derived from rainbow trout (Salmo gairdneri) hepatoma
Lu et al. Establishment and characterization of 13 cell lines from a green turtle (Chelonia mydas) with fibropapillomas
McAllister et al. Colonial growth in agar of cells derived from adenovirus-induced hamster tumors
Frerichs In vitro culture of embryonic cells from the freshwater prawn Macrobrachium rosenbergii
CN112481216A (en) Human induced pluripotent stem cell and culture method and application thereof
JP3038370B2 (en) Method of creating suspension culture cell line
US3935066A (en) Cell lines
Deschatrette Dedifferentiated variants of a rat hepatoma: partial reversion induced by cell aggregation
Andresen et al. Characterization and spontaneous neoplastic transformation of mouse embryo cells isolated and continuously cultured in vitro in chemically defined medium NCTC 135
GB1604003A (en) Process for the cultivation of viruses
Lunger et al. Reptilia-related viruses
Smiley et al. A comparison of secondary palate development with different in vitro techniques
Nicholson Growth of fish cell lines on microcarriers
JP3982843B2 (en) Method for sequential culture of animal cells using porous carrier
Petkus et al. Pure spherules of Coccidioides immitis in continuous culture
Wright et al. Tumorigenicity and antigenicity of mouse cells infected with simian virus 40. I. Relationship of growth in vitro and in vivo in immunosuppressed and immunocompetent recipients
Koment et al. Characterization of a reptilian epithelioid skin cell line derived from the green sea turtle, Chelonia mydas
Rabin et al. Characteristics of Herpesvirus saimiri-induced lymphoma cells in tissue culture
JPS62500001A (en) cell proliferation
Weichselbaum et al. A technique for developing established cell lines from human osteosarcomas

Legal Events

Date Code Title Description
S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R370 Written measure of declining of transfer procedure

Free format text: JAPANESE INTERMEDIATE CODE: R370

EXPY Cancellation because of completion of term